Stock Information
Enliven Therapeutics Inc (ELVN)
Ticker Symbol: ELVN
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $1,758.70 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -1.8574
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -24.22%
Latest News
-
Enliven Therapeutics shares are trading higher after HC Wainwright & Co. maintained its Buy rating and raised the price target on the stock from $48 to $56.
Thu, Mar 26, 2026 10:21 AM
-
HC Wainwright & Co. Maintains Buy on Enliven Therapeutics, Raises Price Target to $56
Thu, Mar 26, 2026 8:55 AM
-
Mizuho Maintains Outperform on Enliven Therapeutics, Raises Price Target to $45
Wed, Mar 25, 2026 10:31 AM
-
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Wed, Mar 25, 2026 8:05 AM
Key Financials
Financial data not available
